VSee Health Inc(VSEE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.54 | Insider Own | 17.04% | Shs Outstand | 47.3M | Perf Week | -30.28% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 46.2M | Perf Month | -52.64% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 8.86% | Short Float | 3.57% | Perf Quarter | -71.4% |
| Income | -0.01B | P/S | 0.19 | EPS this Y | - | Inst Trans | -0.55% | Short Ratio | 0.18 | Perf Half Y | -86.43% |
| Sales | 0.01B | P/B | 0.38 | EPS next 5Y | - | ROA | -69.53% | Short Interest | 1.65M | Perf YTD | -86.59% |
| Book/sh | 0.13 | P/C | 2.07 | EPS past 3/5Y | -42.11% -149.66% | ROE | -945.7% | 52W High | -98.01% ($2.52) | Perf Year | -96.34% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | - | ROIC | -188.01% | 52W Low | 2.24% ($0.05) | Perf 3Y | -99.58% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 86.68% | Gross Margin | 46.3% | Volatility(W/M) | 28.65% 15.68% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.25 | Sales Y/Y TTM | 18.05% | Oper. Margin | -74.19% | ATR (14) | 0.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.41 | EPS Q/Q | 77.63% | Profit Margin | -92.37% | RSI (14) | 28.28 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.41 | Sales Q/Q | -4.86% | SMA20 | -42.67% ($0.09) | Beta | 0.46 | Target Price | $5 |
| Payout | - | Debt/Eq | 0.34 | Earnings | - | SMA50 | -58.08% ($0.12) | Rel Volume | 0 | Prev Close | $0.05 |
| Employees | 209 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | - | SMA200 | -85.37% ($0.34) | Avg Volume(3M) | 9.00M | Price | $0.05 |
| IPO | 2021/12/31 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
VSee is a U.S. digital healthcare company that combines its enterprise/hospital-customized video consultation (telehealth) platform "VSee Lab" with the remote ICU and specialist service network of its subsidiary iDoc. It is a small-cap telemedicine specialist whose primary customers include hospitals, medical institutions, and federal correctional facilities.
Over the past 1 year, on the lower side
98% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
VSEE has weak earnings and a weak balance sheet
Of every $100 in sales, $74.19 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $19. Peers typically go for $86.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -99.6%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 8.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VXF Vanguard Extended Market Index ETF <0.01% It ranks #39 of 41 in the industry
Based on market cap of $3M.
MGRX#36 Mangoceuticals Inc $4M PER - 
ZCMD#37 Zhongchao Inc $4M PER - 
HCTI#38 Healthcare Triangle Inc $4M PER - VSEE#39 VSee Health Inc $3M PER - 
WORX#39 SCWorx Corp $2M PER - 
FAQ
What kind of company is VSEE?
VSEE belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of VSEE?
The market cap of VSEE is approximately $3M, ranking 5,799 within its sector.
What is the 52-week high and low for VSEE?
VSEE has recorded a 52-week high of $2.52 and a low of $0.05.
